6MD vs RHO6: Side-by-Side Comparison
Compare MEDACTA GROUP S.A. SF-,10 (6MD) and Roche Holding AG (RHO6) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 6MD | RHO6 |
|---|---|---|
| Company | MEDACTA GROUP S.A. SF-,10 | Roche Holding AG |
| Country / Exchange | Switzerland · F | Switzerland · STU |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Drug Manufacturers - General |
| Market cap | EUR 2.81B | — |
| P/E ratio | 29.5 | — |
| Dividend yield | 0.81% | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 683.83M | EUR 63.36B |
| Revenue growth YoY | +15.8% | +1.5% |
| Net income | EUR 95.46M | EUR 12.88B |
| Gross margin | 67.1% | 73.7% |
| Diluted EPS | — | 16.04 |